BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33403025)

  • 41. Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588.
    Wang JY; Jin L; Yan XG; Sherwin S; Farrelly M; Zhang YY; Liu F; Wang CY; Guo ST; Yari H; La T; McFarlane J; Lei FX; Tabatabaee H; Chen JZ; Croft A; Jiang CC; Zhang XD
    J Invest Dermatol; 2016 Nov; 136(11):2277-2286. PubMed ID: 27427486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Augment of Oxidative Damage with Enhanced Photodynamic Process and MTH1 Inhibition for Tumor Therapy.
    Hu JJ; Chen Y; Li ZH; Peng SY; Sun Y; Zhang XZ
    Nano Lett; 2019 Aug; 19(8):5568-5576. PubMed ID: 31262183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MutT Homolog1 has multifaceted role in glioma and is under the apparent orchestration by Hypoxia Inducible factor1 alpha.
    Bhavya B; Easwer HV; Vilanilam GC; Anand CR; Sreelakshmi K; Urulangodi M; Rajalakshmi P; Neena I; Padmakrishnan CJ; Menon GR; Krishnakumar K; Deepti AN; Gopala S
    Life Sci; 2021 Jan; 264():118673. PubMed ID: 33130078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage.
    Magkouta SF; Pappas AG; Vaitsi PC; Agioutantis PC; Pateras IS; Moschos CA; Iliopoulou MP; Kosti CN; Loutrari HV; Gorgoulis VG; Kalomenidis IT
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32554927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The presumed MTH1-inhibitor TH588 sensitizes colorectal carcinoma cells to ionizing radiation in hypoxia.
    Pompsch M; Vogel J; Classen F; Kranz P; Iliakis G; Riffkin H; Brockmeier U; Metzen E
    BMC Cancer; 2018 Nov; 18(1):1190. PubMed ID: 30497423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Existence of MTH1-independent 8-oxodGTPase Activity in Cancer Cells as a Compensatory Mechanism against On-target Effects of MTH1 Inhibitors.
    Samaranayake GJ; Troccoli CI; Zhang L; Huynh M; Jayaraj CJ; Ji D; McPherson L; Onishi Y; Nguyen DM; Robbins DJ; Karbaschi M; Cooke MS; Barrientos A; Kool ET; Rai P
    Mol Cancer Ther; 2020 Feb; 19(2):432-446. PubMed ID: 31744893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting MutT Homolog 1 (MTH1) for Breast Cancer Suppression by Using a Novel MTH1 Inhibitor MA-24 with Tumor-Selective Toxicity.
    Kang N; Ma J; Hu Y; Di R; Wang L; Zhang X; Lai Y; Liu Y
    Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure of human MTH1, a Nudix family hydrolase that selectively degrades oxidized purine nucleoside triphosphates.
    Mishima M; Sakai Y; Itoh N; Kamiya H; Furuichi M; Takahashi M; Yamagata Y; Iwai S; Nakabeppu Y; Shirakawa M
    J Biol Chem; 2004 Aug; 279(32):33806-15. PubMed ID: 15133035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutational specificity of mice defective in the MTH1 and/or the MSH2 genes.
    Egashira A; Yamauchi K; Yoshiyama K; Kawate H; Katsuki M; Sekiguchi M; Sugimachi K; Maki H; Tsuzuki T
    DNA Repair (Amst); 2002 Nov; 1(11):881-93. PubMed ID: 12531017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological significance of the defense mechanisms against oxidative damage in nucleic acids caused by reactive oxygen species: from mitochondria to nuclei.
    Nakabeppu Y; Tsuchimoto D; Ichinoe A; Ohno M; Ide Y; Hirano S; Yoshimura D; Tominaga Y; Furuichi M; Sakumi K
    Ann N Y Acad Sci; 2004 Apr; 1011():101-11. PubMed ID: 15126288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation and development of MTH1 inhibitors for treatment of cancer.
    Warpman Berglund U; Sanjiv K; Gad H; Kalderén C; Koolmeister T; Pham T; Gokturk C; Jafari R; Maddalo G; Seashore-Ludlow B; Chernobrovkin A; Manoilov A; Pateras IS; Rasti A; Jemth AS; Almlöf I; Loseva O; Visnes T; Einarsdottir BO; Gaugaz FZ; Saleh A; Platzack B; Wallner OA; Vallin KS; Henriksson M; Wakchaure P; Borhade S; Herr P; Kallberg Y; Baranczewski P; Homan EJ; Wiita E; Nagpal V; Meijer T; Schipper N; Rudd SG; Bräutigam L; Lindqvist A; Filppula A; Lee TC; Artursson P; Nilsson JA; Gorgoulis VG; Lehtiö J; Zubarev RA; Scobie M; Helleday T
    Ann Oncol; 2016 Dec; 27(12):2275-2283. PubMed ID: 27827301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular genetics and structural biology of human MutT homolog, MTH1.
    Nakabeppu Y
    Mutat Res; 2001 Jun; 477(1-2):59-70. PubMed ID: 11376687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of MTH1 gene function in mice with targeted mutagenesis.
    Tsuzuki T; Egashira A; Kura S
    Mutat Res; 2001 Jun; 477(1-2):71-8. PubMed ID: 11376688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species.
    Qing X; Shao Z; Lv X; Pu F; Gao F; Liu L; Shi D
    Anticancer Drugs; 2018 Apr; 29(4):341-352. PubMed ID: 29420337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
    Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
    Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate pyrophosphohydrolase activity of human and mouse MTH1 proteins does not depend on the proliferation rate.
    Bialkowski K; Kasprzak KS
    Free Radic Biol Med; 2004 Nov; 37(10):1534-41. PubMed ID: 15477005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glioblastoma and glioblastoma stem cells are dependent on functional MTH1.
    Pudelko L; Rouhi P; Sanjiv K; Gad H; Kalderén C; Höglund A; Squatrito M; Schuhmacher AJ; Edwards S; Hägerstrand D; Berglund UW; Helleday T; Bräutigam L
    Oncotarget; 2017 Oct; 8(49):84671-84684. PubMed ID: 29156675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PRDX1 and MTH1 cooperate to prevent ROS-mediated inhibition of telomerase.
    Ahmed W; Lingner J
    Genes Dev; 2018 May; 32(9-10):658-669. PubMed ID: 29773556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MTH1 as a target to alleviate T cell driven diseases by selective suppression of activated T cells.
    Karsten S; Fiskesund R; Zhang XM; Marttila P; Sanjiv K; Pham T; Rasti A; Bräutigam L; Almlöf I; Marcusson-Ståhl M; Sandman C; Platzack B; Harris RA; Kalderén C; Cederbrant K; Helleday T; Warpman Berglund U
    Cell Death Differ; 2022 Jan; 29(1):246-261. PubMed ID: 34453118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recognition of nucleotide analogs containing the 7,8-dihydro-8-oxo structure by the human MTH1 protein.
    Kamiya H; Cadena-Amaro C; Dugué L; Yakushiji H; Minakawa N; Matsuda A; Pochet S; Nakabeppu Y; Harashima H
    J Biochem; 2006 Dec; 140(6):843-9. PubMed ID: 17071637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.